NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Biotechnology · USD

Moolec Science SA (MLEC) Stock Analysis

Moolec Science SA (MLEC) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.

MLEC

$6.93

−$0.21 (−2.94%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MLEC with… →

MLEC Key Statistics

As of Sep 4, 2026
Trading
Open
$7.05
Previous Close
$7.14
Day's Range
6.92–7.05
52-Week Range
3.08–23.22
Volume
4.20K
Valuation
Market Cap
$5.03M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−199.02
Financials (FY)
Revenue (FY)
$333.61M−28.47%
Net Income (FY)
−$111.46M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
726.12K
1-Year Return
−60.85%
Dividend and dates
Avg Volume
12.20K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MLEC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+81.18%
2025−96.81%
2024−67.48%
2023−79.67%
2022+22.72%
2021 (partial year)+0.51%

As of September 4, 2026.

MLEC Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$333.61M−$111.46M−33.4%
2024$466.38M−$32.69M−7.0%
2023$420.87M$40.44M9.6%
2022$0.00−$4.53M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$333.61M$125.74M−$3.51M−$111.46M−33.4%
2024$466.38M$179.31M$41.76M−$32.69M−7.0%
2023$420.87M$179.22M$50.61M$40.44M9.6%
2022$0.00$0.00−$3.65M−$4.53M—

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

MLEC Valuation vs Biotechnology Median

Median of 656 stocks
MetricMLECBiotechnology medianvs median
Profit margin0.00%0.00%0.0 pts above

Medians across 656 Biotechnology stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Moolec Science SA (MLEC) at $5.03M. The company sits in the Healthcare sector, in the Biotechnology industry.

MLEC last closed at $6.93 on September 4, 2026. That is −$0.21 (−2.94%) against the previous close. Over the past 52 weeks the price has ranged from $3.08 to $23.22. The latest close sits 125.37% above that 52-week low.

Financial Health

In fiscal 2025, Moolec Science SA reported revenue of $333.61M. Against the prior fiscal year total of $466.38M, that is a change of −28.47%. The same year closed with a net loss of $111.46M. The reported profit margin is 0%. Earnings per share on a trailing basis come to −199.02.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $333.61M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Annualized volatility over the trailing 5 years is 172.38%. Over the trailing twelve months the price has returned −60.85%. Across 5 years the annualized return works out at −65.75%.

Growth & Income

No dividend is on file for MLEC.

So far in 2026 the price is +81.18%. The strongest complete calendar year on file is 2022 at +22.72%; the weakest is 2025 at −96.81%. Of the 4 complete calendar years on file, 1 finished higher.

Peer Comparison

Moolec Science SA (MLEC) operates in the Biotechnology industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Moolec Science SA MLEC $5.03M —
Vertex Pharmaceuticals Incorporated VRTX $138.42B 32.5
Regeneron Pharmaceuticals, Inc. REGN $85.22B 20.5
argenx SE ARGX $64.25B 40.1

The Biotechnology industry average P/E ratio is 12.6x. Moolec Science SA has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Biotechnology Stocks

VRTX

Vertex Pharmaceuticals Incorporated

$138.42B

 REGN

Regeneron Pharmaceuticals, Inc.

$85.22B

 ARGX

argenx SE

$64.25B

 MRNA

Moderna, Inc.

$58.11B

 RVMD

Revolution Medicines, Inc.

$45.01B

 ONC

BeOne Medicines AG

$40.53B
View all Biotechnology stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Moolec Science SA

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Visit website →